Arguing against the proposed definition changes of PD

Bradley F Boeve, Dennis W Dickson, John E. Duda, Tanis Jill Ferman, Douglas R. Galasko, James E. Galvin, Jennifer G. Goldman, John H. Growdon, Howard I. Hurtig, Daniel I. Kaufer, Kejal M Kantarci, James B. Leverenz, Carol F. Lippa, Oscar L. Lopez, Ian G. Mckeith, Andrew B. Singleton, Angela Taylor, Debby Tsuang, Daniel Weintraub, Cyrus P. Zabetian

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

As members of the Lewy Body Dementia Association Scientific Advisory Council, we aim to address some of the issues raised in the article titled "Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease." In particular, we suggest that the 1-year rule distinguishing Parkinson's disease dementia from dementia with Lewy bodies is worth maintaining because it serves an important purpose in clinical practice and clinical and basic science research and when helping the lay community understand the complexity of these different clinical phenotypes. Furthermore, we believe that adding an additional diagnostic label, "PD (dementia with Lewy bodies subtype)," will confuse rather than clarify the distinction between dementia with Lewy bodies and PD or PD dementia, and will not improve management or expedite therapeutic development. We present arguments supporting our contentions.

Original languageEnglish (US)
JournalMovement Disorders
DOIs
StateAccepted/In press - 2016

Fingerprint

Lewy Body Disease
Parkinson Disease
Dementia
Advisory Committees
Phenotype
Research
Therapeutics

Keywords

  • Dementia
  • Dementia with Lewy bodies
  • Parkinson's disease
  • Parkinsonism

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Arguing against the proposed definition changes of PD. / Boeve, Bradley F; Dickson, Dennis W; Duda, John E.; Ferman, Tanis Jill; Galasko, Douglas R.; Galvin, James E.; Goldman, Jennifer G.; Growdon, John H.; Hurtig, Howard I.; Kaufer, Daniel I.; Kantarci, Kejal M; Leverenz, James B.; Lippa, Carol F.; Lopez, Oscar L.; Mckeith, Ian G.; Singleton, Andrew B.; Taylor, Angela; Tsuang, Debby; Weintraub, Daniel; Zabetian, Cyrus P.

In: Movement Disorders, 2016.

Research output: Contribution to journalArticle

Boeve, BF, Dickson, DW, Duda, JE, Ferman, TJ, Galasko, DR, Galvin, JE, Goldman, JG, Growdon, JH, Hurtig, HI, Kaufer, DI, Kantarci, KM, Leverenz, JB, Lippa, CF, Lopez, OL, Mckeith, IG, Singleton, AB, Taylor, A, Tsuang, D, Weintraub, D & Zabetian, CP 2016, 'Arguing against the proposed definition changes of PD', Movement Disorders. https://doi.org/10.1002/mds.26721
Boeve, Bradley F ; Dickson, Dennis W ; Duda, John E. ; Ferman, Tanis Jill ; Galasko, Douglas R. ; Galvin, James E. ; Goldman, Jennifer G. ; Growdon, John H. ; Hurtig, Howard I. ; Kaufer, Daniel I. ; Kantarci, Kejal M ; Leverenz, James B. ; Lippa, Carol F. ; Lopez, Oscar L. ; Mckeith, Ian G. ; Singleton, Andrew B. ; Taylor, Angela ; Tsuang, Debby ; Weintraub, Daniel ; Zabetian, Cyrus P. / Arguing against the proposed definition changes of PD. In: Movement Disorders. 2016.
@article{7da78c3cd8d446e3960c692aae2ff39c,
title = "Arguing against the proposed definition changes of PD",
abstract = "As members of the Lewy Body Dementia Association Scientific Advisory Council, we aim to address some of the issues raised in the article titled {"}Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease.{"} In particular, we suggest that the 1-year rule distinguishing Parkinson's disease dementia from dementia with Lewy bodies is worth maintaining because it serves an important purpose in clinical practice and clinical and basic science research and when helping the lay community understand the complexity of these different clinical phenotypes. Furthermore, we believe that adding an additional diagnostic label, {"}PD (dementia with Lewy bodies subtype),{"} will confuse rather than clarify the distinction between dementia with Lewy bodies and PD or PD dementia, and will not improve management or expedite therapeutic development. We present arguments supporting our contentions.",
keywords = "Dementia, Dementia with Lewy bodies, Parkinson's disease, Parkinsonism",
author = "Boeve, {Bradley F} and Dickson, {Dennis W} and Duda, {John E.} and Ferman, {Tanis Jill} and Galasko, {Douglas R.} and Galvin, {James E.} and Goldman, {Jennifer G.} and Growdon, {John H.} and Hurtig, {Howard I.} and Kaufer, {Daniel I.} and Kantarci, {Kejal M} and Leverenz, {James B.} and Lippa, {Carol F.} and Lopez, {Oscar L.} and Mckeith, {Ian G.} and Singleton, {Andrew B.} and Angela Taylor and Debby Tsuang and Daniel Weintraub and Zabetian, {Cyrus P.}",
year = "2016",
doi = "10.1002/mds.26721",
language = "English (US)",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Arguing against the proposed definition changes of PD

AU - Boeve, Bradley F

AU - Dickson, Dennis W

AU - Duda, John E.

AU - Ferman, Tanis Jill

AU - Galasko, Douglas R.

AU - Galvin, James E.

AU - Goldman, Jennifer G.

AU - Growdon, John H.

AU - Hurtig, Howard I.

AU - Kaufer, Daniel I.

AU - Kantarci, Kejal M

AU - Leverenz, James B.

AU - Lippa, Carol F.

AU - Lopez, Oscar L.

AU - Mckeith, Ian G.

AU - Singleton, Andrew B.

AU - Taylor, Angela

AU - Tsuang, Debby

AU - Weintraub, Daniel

AU - Zabetian, Cyrus P.

PY - 2016

Y1 - 2016

N2 - As members of the Lewy Body Dementia Association Scientific Advisory Council, we aim to address some of the issues raised in the article titled "Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease." In particular, we suggest that the 1-year rule distinguishing Parkinson's disease dementia from dementia with Lewy bodies is worth maintaining because it serves an important purpose in clinical practice and clinical and basic science research and when helping the lay community understand the complexity of these different clinical phenotypes. Furthermore, we believe that adding an additional diagnostic label, "PD (dementia with Lewy bodies subtype)," will confuse rather than clarify the distinction between dementia with Lewy bodies and PD or PD dementia, and will not improve management or expedite therapeutic development. We present arguments supporting our contentions.

AB - As members of the Lewy Body Dementia Association Scientific Advisory Council, we aim to address some of the issues raised in the article titled "Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease." In particular, we suggest that the 1-year rule distinguishing Parkinson's disease dementia from dementia with Lewy bodies is worth maintaining because it serves an important purpose in clinical practice and clinical and basic science research and when helping the lay community understand the complexity of these different clinical phenotypes. Furthermore, we believe that adding an additional diagnostic label, "PD (dementia with Lewy bodies subtype)," will confuse rather than clarify the distinction between dementia with Lewy bodies and PD or PD dementia, and will not improve management or expedite therapeutic development. We present arguments supporting our contentions.

KW - Dementia

KW - Dementia with Lewy bodies

KW - Parkinson's disease

KW - Parkinsonism

UR - http://www.scopus.com/inward/record.url?scp=84989323124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989323124&partnerID=8YFLogxK

U2 - 10.1002/mds.26721

DO - 10.1002/mds.26721

M3 - Article

C2 - 27492190

AN - SCOPUS:84989323124

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

ER -